Did Kasich Just Do an About-Face on Climate Change?
Maybe it’s because he is still feeling his way as a late entrant into the GOP presidential campaign, but Ohio Gov. John Kasich did a fairly dramatic about-face over the weekend on the politically charged issue of climate change.
Kasich, a former House Budget Committee chair and Wall Street business executive, has positioned himself as a “kinder, gentler” conservative than Jeb Bush, Ted Cruz and the dozen other Republicans running for the 2016 presidential nomination. So it wasn’t surprising that he would take a more moderate stand on global warming during the first nationally televised GOP presidential debate Thursday evening.
Related: 10 Things You Need to Know About John Kasich
Kasich, a devout Christian, declared during the two-hour debate sponsored by Fox News that climate change is a real problem requiring government and society to protect the “creation that the Lord has given us.”
While the vast majority of Republicans on Capitol Hill and the campaign trail are highly skeptical of President Obama’s campaign to curb industrial carbon emissions to prevent the disastrous long term effects of global warming on the environment and economy, Kasich appeared to be one of the few who took the threat seriously.
He emphasized the importance of unity and cooperation, saying at one point that “we’ve got to unite our country again, because we’re stronger when we are united and we are weaker when we are divided.”
Just a few days later, though, after winning plaudits for his Thursday night performance – with some even favorably comparing his views on environmental threats to those of Pope Francis – Kasich sounded much like a climate-change doubter.
Related: Does Kasich Have a Chance? How He Can Catch Up to the GOP
During an appearance on NBC News’ “Meet the Press,” Kasich told moderator Chuck Todd that “I think man absolutely affects the environment, but as to whether, you know, what the impact is, the overall impact, I think that’s a legitimate debate.”
Kasich went on to say that in Ohio, “we preciously take care of Lake Erie, and we’ve reduced emissions by 30 percent over the last ten years.”
“We believe in alternative energy,” he added. “So of course we have to be sensitive to it, but we don’t want to destroy people’s jobs, based on some theory that’s not proven.”
According to National Journal, the Kasich 2016 campaign attempted to clarify his remarks following his appearance on “Meet the Press.” "The governor has long believed climate change is real and we need to do something about it,” according to the statement. “The debate over exact percentages of why it is happening is less important than what can be done about it. We know it is real, we know man has an impact, and we know we need to do something."
A number of prominent presidential candidates -- including former Florida governor Jeb Bush and Sens. Ted Cruz, Marco Rubio, and Rand Paul -- are climate change doubters or deniers. Sen. Lindsey Graham of South Carolina is one of the few who unquestionably accepts scientific evidence that man-made greenhouse gas emissions are a principal cause of global warming, and has sharply criticized his party for lacking a comprehensive environmental platform.
Top Reads From The Fiscal Times:
- How GOP Candidates Would Steer U.S. Foreign Policy
- Fiorina Takes on Trump in a Brave Battle of the Sexes
- As Politicians Bicker Over Funding, Military Families Cut Back on Vacations
Chart of the Day: High Deductible Blues
The higher the deductible in your health insurance plan, the less happy you probably are with it. That’s according to a new report on employer-sponsored health insurance from the Kaiser Family Foundation and the Los Angeles Times.
Chart of the Day: Tax Cuts and the Missing Capex Boom
Despite the Republican tax overhaul, businesses aren’t significantly increasing their capital expenditures. “The federal government will have to borrow an added $1 trillion through 2027 to pay for the corporate tax breaks,” says Bloomberg’s Mark Whitehouse. “So far, it’s hard to see what the country is getting in return.”
Chart of the Day: 2019’s Lobbying Leaders
Roll Call reports that trade, infrastructure and health care issues including prescription drug prices “dominated the lobbying agendas of some of the biggest spenders on K Street early this year.” Here’s Roll Call’s look at the top lobbying spenders so far this year:
Can You Fix Social Security? A New Tool Lets You Try
The Congressional Budget Office released an interactive tool Wednesday that shows how some widely discussed policy changes would affect the long-run financial health of the Social Security system.
“This interactive tool allows the user to explore seven policy options that could be used to improve the Social Security program’s finances and delay the trust funds’ exhaustion,” CBO said. “Four options would reduce benefits, and three options would increase payroll taxes. The tool allows for any combination of those options. It also lets the user change implementation dates and choose whether to show scheduled or payable benefits. … The tool also shows the impact of the options on different groups of people.”
Click here to view the interactive tool on the CBO website.
Why Prescription Drug Prices Keep Rising – and 3 Ways to Bring Them Down
Prescription drug prices have been rising at a blistering rate over the last few decades. Between 1980 and 2016, overall spending on prescription drugs rose from about $12 billion to roughly $330 billion, while its share of total health care spending doubled, from 5% to 10%.
Although lawmakers have shown renewed interest in addressing the problem, with pharmaceutical CEOs testifying before the Senate Finance Committee in February and pharmacy benefit managers (PBMS) scheduled to do so this week, no comprehensive plan to halt the relentless increase in prices has been proposed, let alone agreed upon.
Robin Feldman, a professor at the University of California Hastings College of Law, takes a look at the drug pricing system in a new book, “Drugs, Money and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices.” In a recent conversation with Bloomberg’s Joe Nocera, Feldman said that one of the key drivers of rising prices is the ongoing effort of pharmaceutical companies to maintain control of the market.
Fearing competition from lower-cost generics, drugmakers began over the last 10 or 15 years to focus on innovations “outside of the lab,” Feldman said. These innovations include paying PBMs to reduce competition from generics; creating complex systems of rebates to PBMs, hospitals and doctors to maintain high prices; and gaming the patent system to extend monopoly pricing power.
Feldman’s research on the dynamics of the drug market led her to formulate three general solutions for the problem of ever-rising prices:
1) Transparency: The current system thrives on secret deals between drug companies and middlemen. Transparency “lets competitors figure out how to compete and it lets regulators see where the bad behaviors occur,” Feldman says.
2) Patent limitations: Drugmakers have become experts at extending patents on existing drugs, often by making minor modifications in formulation, dosage or delivery. Feldman says that 78% of drugs getting new patents are actually old drugs gaining another round of protection, and thus another round of production and pricing exclusivity. A “one-and-done” patent system would eliminate this increasingly common strategy.
3) Simplification: Feldman says that “complexity breeds opportunity,” and warns that the U.S. “drug price system is so complex that the gaming opportunities are endless.” While “ruthless simplification” of regulatory rules and approval systems could help eliminate some of those opportunities, Feldman says that the U.S. doesn’t seem to be moving in this direction.
Read the full interview at Bloomberg News.